EA200000875A1 - Белки, взаимодействующие с каспазой-8 - Google Patents
Белки, взаимодействующие с каспазой-8Info
- Publication number
- EA200000875A1 EA200000875A1 EA200000875A EA200000875A EA200000875A1 EA 200000875 A1 EA200000875 A1 EA 200000875A1 EA 200000875 A EA200000875 A EA 200000875A EA 200000875 A EA200000875 A EA 200000875A EA 200000875 A1 EA200000875 A1 EA 200000875A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- caspase
- proteins interacting
- proteins
- interacting
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01033—N-Acetylglucosamine deacetylase (3.5.1.33)
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Описываются белки, взаимодействующие с каспазой-8. Также описываются получение и применение таких белков.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12772198A IL127721A0 (en) | 1998-12-24 | 1998-12-24 | Caspase-8 interacting proteins |
IL13210599A IL132105A0 (en) | 1998-12-24 | 1999-09-28 | Caspase-8 interacting proteins |
PCT/IL1999/000698 WO2000039160A2 (en) | 1998-12-24 | 1999-12-23 | Caspase-8 interacting proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200000875A1 true EA200000875A1 (ru) | 2001-10-22 |
EA005853B1 EA005853B1 (ru) | 2005-06-30 |
Family
ID=26323761
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000875A EA005853B1 (ru) | 1998-12-24 | 1999-12-23 | N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения |
EA200401390A EA007273B1 (ru) | 1998-12-24 | 1999-12-23 | Выделенный полипептид, связывающийся с каспазой -8, и способы его применения |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200401390A EA007273B1 (ru) | 1998-12-24 | 1999-12-23 | Выделенный полипептид, связывающийся с каспазой -8, и способы его применения |
Country Status (20)
Country | Link |
---|---|
US (3) | US6762283B1 (ru) |
EP (1) | EP1058691A1 (ru) |
JP (1) | JP2002536965A (ru) |
KR (2) | KR100646075B1 (ru) |
CN (2) | CN1603342A (ru) |
AR (1) | AR029321A1 (ru) |
AU (1) | AU780585B2 (ru) |
BG (2) | BG65375B1 (ru) |
BR (1) | BR9909252A (ru) |
CA (1) | CA2321672A1 (ru) |
EA (2) | EA005853B1 (ru) |
EE (1) | EE200000487A (ru) |
HK (1) | HK1037197A1 (ru) |
HU (1) | HUP0100671A3 (ru) |
IL (3) | IL178921A0 (ru) |
NO (1) | NO20004167L (ru) |
NZ (1) | NZ506477A (ru) |
PL (1) | PL350181A1 (ru) |
SK (1) | SK12682000A3 (ru) |
WO (1) | WO2000039160A2 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA009956B1 (ru) * | 2001-09-04 | 2008-04-28 | Йеда Рисерч Энд Дивелопмент Ко. Лтд. | Внутриклеточный полипептид (cari) и способы его применения |
US20040072770A1 (en) * | 2002-07-03 | 2004-04-15 | Besterman Jeffrey M. | Methods for specifically inhibiting histone deacetylase-7 and 8 |
IL158599A0 (en) * | 2003-10-26 | 2004-05-12 | Yeda Res & Dev | Methods of modulating hematopoiesis |
MX2009008914A (es) * | 2007-02-23 | 2009-08-28 | Yeda Res & Dev | Anticuerpos y composiciones farmaceuticas que contienen los mismos, utiles para inhibir la actividad de metaloproteinas. |
WO2010006177A2 (en) * | 2008-07-10 | 2010-01-14 | Dana-Farber Cancer Institute, Inc. | Muc1, caspase-8,and ded-containing proteins |
CN114480393A (zh) * | 2014-09-04 | 2022-05-13 | 纪念斯隆-凯特琳癌症中心 | 用于治疗血红蛋白病的球蛋白基因治疗 |
CN104694485A (zh) * | 2015-02-13 | 2015-06-10 | 广西壮族自治区兽医研究所 | Z-ietd-fmk在提高prrsv体外培养滴度方面的应用及其方法 |
CN106146665B (zh) * | 2016-08-31 | 2019-08-09 | 中国农业科学院植物保护研究所 | 一种用于制备针对甜菜夜蛾caspase-5大亚基的抗体的方法 |
KR102361890B1 (ko) * | 2017-03-16 | 2022-02-10 | 임문워크 아이엔씨 | 링커 유닛 및 이를 포함하는 분자 구조물 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL73883A (en) * | 1984-12-20 | 1990-12-23 | Yeda Res & Dev | Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha |
IL83878A (en) * | 1987-09-13 | 1995-07-31 | Yeda Res & Dev | Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it |
IL94039A (en) * | 1989-08-06 | 2006-09-05 | Yeda Res & Dev | Antibodies to tbp - 1 and their use |
JPH0625292A (ja) * | 1990-10-31 | 1994-02-01 | Mitsui Toatsu Chem Inc | タンパク質及びその遺伝子 |
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
AU3665893A (en) * | 1992-02-12 | 1993-09-03 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Sequences characteristic of human gene transcription product |
US5364503A (en) | 1992-02-20 | 1994-11-15 | Macmillan Bloedel Limited | Nitric oxide treatment for ozone bleaching |
IL101769A (en) * | 1992-05-03 | 2007-02-11 | Yeda Res & Dev | Modulation of TNF receptor action |
IL104355A (en) * | 1993-01-10 | 2006-08-20 | Yeda Res & Dev | Tnf receptor promoter |
IL109633A (en) * | 1994-05-11 | 2005-05-17 | Yeda Res & Dev | Tnf receptor promoter |
WO1997048797A1 (en) * | 1996-06-17 | 1997-12-24 | Genzyme Corporation | Novel human chromosome 16 genes, compositions, methods of making and using same |
US6242569B1 (en) * | 1997-02-05 | 2001-06-05 | Tularik, Inc. | Regulators of apoptosis |
WO1999061626A2 (en) * | 1998-05-29 | 1999-12-02 | Incyte Pharmaceuticals, Inc. | Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
US6326354B1 (en) * | 1998-08-19 | 2001-12-04 | Washington University | Modulation of apoptosis with bid |
CA2350415A1 (en) * | 1998-11-18 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Inflammation-associated genes |
EP1002900A1 (de) | 1998-11-18 | 2000-05-24 | SP Beton GmbH & Co. KG | Verkehrsflächen-Bodenbelag mit Bodenbelagelementen aus Kunststeinmaterial |
-
1999
- 1999-09-28 IL IL178921A patent/IL178921A0/en unknown
- 1999-09-28 IL IL13210599A patent/IL132105A0/xx unknown
- 1999-12-23 CN CNA2004100563830A patent/CN1603342A/zh active Pending
- 1999-12-23 NZ NZ506477A patent/NZ506477A/en unknown
- 1999-12-23 SK SK1268-2000A patent/SK12682000A3/sk unknown
- 1999-12-23 BR BR9909252-2A patent/BR9909252A/pt not_active Application Discontinuation
- 1999-12-23 EA EA200000875A patent/EA005853B1/ru not_active IP Right Cessation
- 1999-12-23 EP EP99961257A patent/EP1058691A1/en not_active Withdrawn
- 1999-12-23 KR KR1020067015048A patent/KR100646075B1/ko not_active IP Right Cessation
- 1999-12-23 EE EEP200000487A patent/EE200000487A/xx unknown
- 1999-12-23 CN CNB998053627A patent/CN1223608C/zh not_active Expired - Fee Related
- 1999-12-23 HU HU0100671A patent/HUP0100671A3/hu unknown
- 1999-12-23 WO PCT/IL1999/000698 patent/WO2000039160A2/en active Application Filing
- 1999-12-23 EA EA200401390A patent/EA007273B1/ru unknown
- 1999-12-23 PL PL99350181A patent/PL350181A1/xx not_active IP Right Cessation
- 1999-12-23 AR ARP990106739A patent/AR029321A1/es unknown
- 1999-12-23 KR KR1020007009343A patent/KR100646074B1/ko not_active IP Right Cessation
- 1999-12-23 JP JP2000591071A patent/JP2002536965A/ja active Pending
- 1999-12-23 AU AU17950/00A patent/AU780585B2/en not_active Ceased
- 1999-12-23 CA CA002321672A patent/CA2321672A1/en not_active Abandoned
-
2000
- 2000-08-21 NO NO20004167A patent/NO20004167L/no not_active Application Discontinuation
- 2000-08-22 BG BG104707A patent/BG65375B1/bg unknown
- 2000-08-23 IL IL138025A patent/IL138025A/en not_active IP Right Cessation
- 2000-08-24 US US09/644,827 patent/US6762283B1/en not_active Expired - Fee Related
-
2001
- 2001-11-07 HK HK01107798A patent/HK1037197A1/xx not_active IP Right Cessation
-
2004
- 2004-04-01 US US10/814,160 patent/US7339047B2/en not_active Expired - Fee Related
-
2007
- 2007-07-02 BG BG109904A patent/BG109904A/bg unknown
-
2008
- 2008-01-08 US US11/970,986 patent/US20080139476A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02004666A (es) | Gelatinas recombinantes. | |
DE69729786D1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
ID23374A (id) | Halogenopirimidin | |
AR004357A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos. | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
WO2003011115A3 (en) | Peptide-based multimeric targeted contrast agents | |
EA199800946A1 (ru) | Концентрированный препарат антител | |
FR2770110B1 (fr) | Boitier, du type boitier de maquillage | |
EE03693B1 (et) | Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad | |
DE69905170T2 (de) | Thiazolopyrimidinderivate | |
BR9808491A (pt) | Compostos calcilìticos | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
NO20031860L (no) | Kahalalid F | |
BR0009767A (pt) | Agentes inibitórios e quimiotáticos derivados de osteopontina e seus usos | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
DE69634489D1 (de) | Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon | |
DE59912915D1 (de) | Herstellung von 4,4'-Diketo-carotinoiden | |
TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
ATE385805T1 (de) | Neue peptide | |
PT929299E (pt) | 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
EA200001050A1 (ru) | Малеат пароксетина | |
DE69828906D1 (de) | Herstellung von 1,3 propandiolestern | |
EA200400393A1 (ru) | Антитела против каспазы-8, их получение и применение | |
AR026890A1 (es) | Composiciones de tenocitos, preparaciones y utilizaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |